MARVAX Trademark

Trademark Overview


On Monday, October 24, 2022, a trademark application was filed for MARVAX with the United States Patent and Trademark Office. The USPTO has given the MARVAX trademark a serial number of 97645573. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, February 12, 2024. This trademark is owned by Soligenix, Inc.. The MARVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccine preparations, namely, vaccines for immunization of humans against Marburg Virus Disease
marvax

General Information


Serial Number97645573
Word MarkMARVAX
Filing DateMonday, October 24, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, February 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccine preparations, namely, vaccines for immunization of humans against Marburg Virus Disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateThursday, October 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSoligenix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Monday, February 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 7, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, November 7, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 10, 2023NON-FINAL ACTION E-MAILED
Thursday, August 10, 2023NON-FINAL ACTION WRITTEN
Friday, August 4, 2023ASSIGNED TO EXAMINER
Thursday, October 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 27, 2022NEW APPLICATION ENTERED